Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/16/2010US20100317701 Heterocyclic inhibitors of necroptosis
12/16/2010US20100317698 Polysubstituted Pyridinylaminoalkylene- and Pyridinyloxyalkylene-Cyclopropanamine Compounds, a Process for Their Preparation and Pharmaceutical Compositions Containing Them
12/16/2010US20100317692 Quinolone M1 Receptor Positive Allosteric Modulators
12/16/2010US20100317688 2-HETEROAROYLIMIDAZOL[1,2-a]PYRIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317687 2-BENZOYLIMIDAZO[1,2-a]PYRIDINE DERIVATIVES, PREPARATION THEREOF AND THERAPEUTIC USE THEREOF
12/16/2010US20100317686 N-HETEROCYCLIC-6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317685 N-PHENYL-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317683 Preparation of 6-Alpha-Amino N-Substituted Morphinans by Catalytic Hydrogen Transfer
12/16/2010US20100317682 Single Dosage Unit Including Opioid and Methylnaltrexone or Methylnaltrexone Salt
12/16/2010US20100317679 Substituted aryl-fused spirocyclic amines
12/16/2010US20100317678 Hydroxamates as inhibitors of histone deacetylase
12/16/2010US20100317676 Fused heterocyclic compounds, and compositions and uses thereof
12/16/2010US20100317675 6-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317674 Metabotropic Glutamate-Receptor-Potentiating Isoindolones
12/16/2010US20100317673 N-HETEROCYCLIC-IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
12/16/2010US20100317672 Monomaleate Monohydrate Salt of a 5HT1A Receptor Antagonist
12/16/2010US20100317668 Substituted pyrano [2,3-b] pyridinamine compounds as beta-secretase modulators and methods of use
12/16/2010US20100317662 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286
12/16/2010US20100317656 IMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE DERIVATIVES, PREPARATION THEREOF AND APPLICATION THEREOF IN THERAPEUTICS
12/16/2010US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/16/2010US20100317648 Therapeutic compounds
12/16/2010US20100317646 Compounds
12/16/2010US20100317644 Substituted Sulfonamide Compounds
12/16/2010US20100317639 Medicament Based On a Monoester of Steroids With Long Chain Fatty Acids
12/16/2010US20100317638 Neuroactive 13,24-Cyclo-18,21-Dinorcholanes and Structurally Related Pentacylic Steroids
12/16/2010US20100317635 Treatment of hot flushes, vasomotor symptoms, and night sweats with sex steroid precursors in combination with selective estrogen receptor modulators
12/16/2010US20100317633 Hexahydro-cyclooctyl pyrazole cannabinoid modulators
12/16/2010US20100317631 Gel Composition and Transcrotal Application of a Composition for the Treatment of Hypogonadism
12/16/2010US20100317630 Novel heterocyclic compounds as mglu5 antagonists
12/16/2010US20100317629 Dissolvable pharmaceutical implant
12/16/2010US20100317622 Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids
12/16/2010US20100317620 N-PHENYLIMIDAZO[1,2-a]PYRIDINE-2-CARBOXAMIDE COMPOUNDS, PREPARATION AND THERAPEUTIC USE THEREOF
12/16/2010US20100317619 Selective Agents for Pain Suppression
12/16/2010US20100317618 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1 and cx3cr1
12/16/2010US20100317613 Activity enhancer for detoxifying enzyme
12/16/2010US20100317605 The use of epimedium flavones and effective components thereof for the preparation of medicaments of promoting proliferations and differentiations of nerve cells
12/16/2010US20100317589 Compositions and methods for treatment of multiple sclerosis
12/16/2010US20100317582 Novel cyclic hydrocarbon compounds for the treatment of diseases
12/16/2010US20100317578 Method of protecting against stroke through the use of a delta opioid peptide
12/16/2010US20100317577 Methods and Compositions for Inhibiting Cell Death or Enhacing Cell Proliferation
12/16/2010US20100317109 Factor
12/16/2010US20100316729 Use of Hyperbaric Conditions to Provide Neuroprotection
12/16/2010US20100316727 Treatment of inflammatory disorders with ozone
12/16/2010US20100316712 Pharmaceutical compositions for treatment of parkinson's disease and related disorders
12/16/2010US20100316710 Sustained-release tablet composition of pramipexole
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316695 Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics
12/16/2010US20100316682 Biodegradable Hyaluronic Acid Derivative, Biodegradable Polymeric Micelle Composition and Pharmaceutical or Bioactive Composition
12/16/2010US20100316626 Methods for treatment and diagnosis of psychiatric disorders
12/16/2010US20100316615 Antisense Oligonucleotides Against VR1
12/16/2010US20100316605 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010US20100316590 Compositions and methods related to poloxamer copolymer membrane sealant
12/16/2010US20100316564 Immunological targeting of pathological tau proteins
12/16/2010DE102009025549A1 Zusammensetzung für den Transport von Orotsäure über die Bluthirnschranke Composition for the transport of orotic acid across the blood brain barrier
12/16/2010DE102009024542A1 Zusammensetzungen auf Basis von Chitosan-Oligosacchariden Compositions based on chitosan-oligosaccharides
12/16/2010CA2801842A1 Amorphous varenicline tartrate co-precipitates
12/16/2010CA2774883A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2772869A1 Methods, systems, and compositions for neuronal differentiation of multipotent stromal cells
12/16/2010CA2765291A1 Sublingual apomorphine
12/16/2010CA2765181A1 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
12/16/2010CA2765169A1 Model systems and treatment regimes for treatment of neurological disease
12/16/2010CA2765099A1 Immunological targeting of pathological tau proteins
12/16/2010CA2764989A1 Inhibitors of phosphatidylinositol 3-kinase
12/16/2010CA2764981A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamoylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
12/16/2010CA2764808A1 Histamine h3 inverse agonists and antagonists and methods of use thereof
12/16/2010CA2764807A1 Methods and compositions for the induction of hypothermia
12/16/2010CA2764777A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010CA2764653A1 Tetracyclic compounds
12/16/2010CA2764567A1 Benzimidazole derivatives useful as trpm8 channel modulators
12/16/2010CA2763931A1 Use of substituted oxindole derivatives for the treatment and prophylaxis of pain
12/16/2010CA2762890A1 Neuroprotective properties of 5'-methylthioadenosine
12/16/2010CA2688766A1 Compositions and methods for treatment of multiple sclerosis
12/15/2010EP2261358A2 Novel streptococcus antigen
12/15/2010EP2261254A2 Anti-amyloid antibodies and uses thereof
12/15/2010EP2261235A2 Inhibitors of caspases
12/15/2010EP2261234A2 Inhibitors of caspases
12/15/2010EP2261233A2 Inhibitors of caspases
12/15/2010EP2261232A2 Inhibitors of caspases
12/15/2010EP2261224A2 6-(Pyridinyl)-4-pyrimidone derivatives as tau protein kinase 1 inhibitors
12/15/2010EP2261218A2 Process for preparing phenyl-, pyridinyl- or pyrimidinyl-substituted imidazoles
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260874A1 Aprotinin analogs as carriers across the blood-brain barrier
12/15/2010EP2260869A2 Pharmaceutical product
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260851A1 Use of pentacyclic triterpene for the preparation of a pharmaceutical compound intended for the treatment of multiple sclerosis
12/15/2010EP2260850A2 A2A receptor antogonists for use in the treatment of movement disorders
12/15/2010EP2260844A1 Combination of an NMDA Receptor Antagonist and a Selective Serotonin Reuptake Inhibitor for the Treatment of Depression and other Mood Disorders
12/15/2010EP2260839A2 Combination therapy using 1-aminocyclohexane derivatives and acetylcholinesterase inhibitors
12/15/2010EP2260052A2 Steroid analogues for neuroprotection
12/15/2010EP2260043A1 Substituted sulfonamide derivatives
12/15/2010EP2260042A1 Substituted spirocyclic cyclohexane derivatives
12/15/2010EP2260038A1 Purine derivatives as a3 receptor- selective agonists
12/15/2010EP2260037A2 A polymorphic form of a pyrazino [2,3-h] [3] benzazepine derivative
12/15/2010EP2260033A1 2-benzoylimidazo[1,2-a]pyridine derivatives, preparation thereof and therapeutic use thereof
12/15/2010EP2260022A1 Substituted cyclohexyldiamines
12/15/2010EP2260021A1 Substituted 4-aminocyclohexane derivatives
12/15/2010EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
12/15/2010EP2259783A2 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain
12/15/2010EP2259782A1 Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
12/15/2010EP2259780A2 Pharmaceutical composition comprising naltrexone
1 ... 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 ... 1833